VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite

Body Weight Does Not Predict for Anti-Xa Levels after Fixed Dose Prophylaxis with Enoxaparin After Orthopedic Surgery - The post-arthroplasty screening study

By Kovacs M.J.   Weir K.   MacKinnon K.   Keeney M.   Brien W.F.   Cruickshank M.K.  

Thrombosis Research, Vol. 91, Iss. 3, 1998-08 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis

By Heizmann M.   Baerlocher G.M.   Steinmann F.   Horber F.F.   Wuillemin W.A.  

Thrombosis Research, Vol. 106, Iss. 4, 2002-05 ,pp. : 179-181

Elsevier

Access to resources Recommend Favorite

Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients

By Zambruni A.   Thalheimer U.   Coppell J.   Riddell A.   Mancuso A.   Leandro G.   Perry D.   Burroughs A. K.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 830-836

Informa Healthcare

Access to resources Recommend Favorite

Small Intestinal Bacterial Overgrowth in Patients with Morbid Obesity

By Jouet Pauline   Coffin Benoit   Sabate Jean-Marc  

Digestive Diseases and Sciences, Vol. 56, Iss. 2, 2011-02 ,pp. : 615-616

Springer Publishing Company

Access to resources Recommend Favorite